247-900-1

Applied Filters:

Keyword:'247-900-1'

Showing 1-1 of 1 result for "247-900-1" within Papers

Sequential versus triple therapy for the first-line treatment of Helicobacter pylori: a multicentre, open-label, randomised trial.

Jyh-Ming Liou et al.

Lancet (London, England), 381(9862), 205-213 (2012-11-20)

Whether sequential treatment can replace triple therapy as the standard treatment for Helicobacter pylori infection is unknown. We compared the efficacy of sequential treatment for 10 days and 14 days with triple therapy for 14 days in first-line treatment. For

Page 1 of 1